Search

Displaying results 8891 - 8900 of 10000 in total
  1. Drug

    Vonicog alfa

    go.drugbank.com/drugs/DB12872
    ApprovedInvestigational

    Vonicog alfa is a recombinant human von Willebrand factor (rVWF) produced from Chinese hamster ovary cells. … [A264444] Used to treat von Willebrand Disease (vWD), it mimics the biological actions of endogenous VWF,[L51274] which is a critical plasma glycoprotein involved in platelet adhesion and aggregation.

    Synonyms: (618-THREONINE,709-ASPARTIC ACID)VON WILLEBRAND FACTOR HOMO SAPIENS (1381A>T,1472H>D VARIANT) BLOOD COAGULATION FACTOR
  2. Drug

    Mavatrep

    go.drugbank.com/drugs/DB12875
    Investigational

    Mavatrep has been used in trials studying the treatment of Osteoarthritis, Knee.

    Categories: Heterocyclic Compounds, 2-Ring
  3. Drug

    Oxatomide

    go.drugbank.com/drugs/DB12877
    Approved

    Oxatomide has been used in trials studying the treatment of Muscular Dystrophy, Duchenne.

    Categories: Heterocyclic Compounds, 1-Ring
  4. Drug

    Eltoprazine

    go.drugbank.com/drugs/DB12883
    Investigational

    Eltoprazine has been used in trials studying the treatment of Schizophrenia and Cognitive Impairment.

    Categories: Heterocyclic Compounds, 1-Ring, Serotonin 5-HT2 Receptor Antagonists
  5. Drug

    Dihydrexidine

    go.drugbank.com/drugs/DB12890
    Investigational

    Dihydrexidine has been used in trials studying the treatment of SPD, Cocaine-Related Disorders, and Schizotypal Personality Disorder.

    Categories: Heterocyclic Compounds, 3-Ring
  6. Drug

    Fiacitabine

    go.drugbank.com/drugs/DB12901
    Investigational

    Fiacitabine has been used in trials studying the treatment of HIV Infections and Cytomegalovirus Infections.

    Categories: Heterocyclic Compounds, 1-Ring
  7. Drug

    Zoligratinib

    go.drugbank.com/drugs/DB12903
    Investigational

    Ch5183284 has been used in trials studying the treatment of Solid Tumours.

    Categories: Heterocyclic Compounds, 1-Ring, Heterocyclic Compounds, 2-Ring
  8. Drug

    LY-2334737

    go.drugbank.com/drugs/DB12906
    Investigational

    LY2334737 has been used in trials studying the treatment of Solid Tumor, Metastatic Tumor, and Malignant Solid Tumor.

    Categories: Heterocyclic Compounds, 1-Ring
  9. Drug

    Factor XIII (human)

    go.drugbank.com/drugs/DB12909
    ApprovedInvestigational

    Within the body, FXIII circulates as a heterotetramer composed of 2 A-subunits and 2 B-subunits (A2B2)[A32363]. … As the half-life of endogenous Factor XIII is long (5-11 days), prophylactic therapy with the replacement of FXIII can be given every 4-6 to maintain hemostasis[A32363].

    International brands: Fibrogammin P
  10. Drug

    Bimekizumab

    go.drugbank.com/drugs/DB12917
    ApprovedInvestigational

    Bimekizumab is a humanized monoclonal antibody directed towards IL-17, which was approved for use in the EU on August 20, 2021, for the treatment of plaque psoriasis. … [A244455] It has demonstrated superior efficacy as compared to another IL-17 inhibitor, [secukinumab], as well as [ustekinumab] (an IL-12/23 inhibitor) and [adalimumab] (a TNF inhibitor) in the treatment